(Webinar held February 23, 2022) HDA hosted a panel discussion on maintaining supply chain resiliency through public health crises.

This resource provides information for manufacturers on practices that can improve data quality to aid in DSCSA implementation.

Prepared by technical experts of the HDA Exceptions Handling Work Group, these guidelines were developed to address exceptions that may arise when passing or failing to pass Drug Supply Chain Security...

The 92nd Edition HDA Factbook (2021–2022) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry. The data examined within the report are...

PRICE : $0.00 - $0.00

The 13th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceutical distribution offers insight into this unique marketplace.

PRICE : $0.00 - $0.00

This comprehensive guideline, developed by the distribution-sector experts of HDA’s Bar Code Task Force, provides specifications for bar coding and labeling healthcare products.

The sixth edition of the HDA Research Foundation's survey shares the current readiness of manufacturers and distributors to meet the Drug Supply Chain Security Act (DSCSA) requirements.

The HDA Research Foundation assesses the industry’s progress toward implementing GS1 Electronic Product Code Information Services (EPCIS), as well as trading partner plans for exchanging data, to comply...

This interactive course is made up of 13 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.

This report summarizes the results of the pilot study conducted by HDA, working with Ernst & Young LLP (EY) and HDA’s Traceability Pilots Work Group.

PRICE : $0.00 - $0.00